首页 > 最新文献

Gland surgery最新文献

英文 中文
Cardiovascular and fracture events analysis and intervention strategies in patients undergoing parathyroidectomy with secondary hyperparathyroidism. 接受甲状旁腺切除术的继发性甲状旁腺功能亢进症患者的心血管和骨折事件分析及干预策略。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-391
Suyi Xu, Danni Xu, Jun Wu, Jianwen Fan, Marti Manyalich-Blasi, Huafen Wang

Background: Chronic kidney disease (CKD), especially end-stage renal disease (ESRD), is the most common cause of secondary hyperparathyroidism (SHPT), and SHPT is the most severe complication of ESRD. This study aimed to analyze the influencing factors of cardiovascular and fracture events in patients with SHPT which are the leading causes of death in patients with CKD, and provide a reference for selecting patients for whom surgery is more suitable.

Methods: Patients who underwent parathyroidectomy (PTX) for SHPT at The First Affiliated Hospital, Zhejiang University School of Medicine from September 2021 to April 2024 were selected as the study object, with the inclusion and exclusion criteria as followed. They were divided into rural and urban residents for comparison as a cross-sectional study. The study evaluated the comorbidities, socioeconomic status, and postoperative complications diagnosed by radiography of patients undergoing surgery for SHPT.

Results: A total of 119 patients were included, among whom, 71 were from rural areas and 48 were from urban areas. Compared with urban residents, rural residents had poorer economic conditions, a longer interval from disease onset to PTX, and a higher incidence of cardiovascular and fracture events and concurrent nephrolithiasis, all of which were statistically significant. Multivariate analysis indicated that place of residence, age, and duration of uremia were independent risk factors of cardiovascular/fracture events.

Conclusions: Medical staff in ESRD outpatient clinics should pay attention to patients with SHPT. ESRD patients should have better surveillance especially for rural, elder and poor phosphorus control patients, and promptly assess surgical intervention measures.

背景:慢性肾脏病(CKD),尤其是终末期肾病(ESRD),是继发性甲状旁腺功能亢进症(SHPT)最常见的病因,而SHPT是ESRD最严重的并发症。SHPT是导致CKD患者死亡的主要原因,本研究旨在分析SHPT患者发生心血管和骨折事件的影响因素,为选择更适合手术治疗的患者提供参考:选择 2021 年 9 月至 2024 年 4 月在浙江大学医学院附属第一医院接受甲状旁腺切除术(PTX)的 SHPT 患者作为研究对象,纳入和排除标准如下。作为横断面研究,他们被分为农村居民和城市居民进行比较。研究评估了接受手术治疗的 SHPT 患者的合并症、社会经济状况以及通过放射学诊断的术后并发症:共纳入 119 名患者,其中 71 人来自农村地区,48 人来自城市地区。与城市居民相比,农村居民的经济条件较差,从发病到 PTX 的间隔时间较长,心血管和骨折事件以及并发肾结石的发生率较高,所有这些因素均有统计学意义。多变量分析表明,居住地、年龄和尿毒症持续时间是心血管/骨折事件的独立风险因素:结论:ESRD门诊医务人员应关注SHPT患者。结论:ESRD门诊医务人员应关注SHPT患者,对ESRD患者应加强监测,尤其是农村、老年人和血磷控制不佳的患者,并及时评估手术干预措施。
{"title":"Cardiovascular and fracture events analysis and intervention strategies in patients undergoing parathyroidectomy with secondary hyperparathyroidism.","authors":"Suyi Xu, Danni Xu, Jun Wu, Jianwen Fan, Marti Manyalich-Blasi, Huafen Wang","doi":"10.21037/gs-24-391","DOIUrl":"https://doi.org/10.21037/gs-24-391","url":null,"abstract":"<p><strong>Background: </strong>Chronic kidney disease (CKD), especially end-stage renal disease (ESRD), is the most common cause of secondary hyperparathyroidism (SHPT), and SHPT is the most severe complication of ESRD. This study aimed to analyze the influencing factors of cardiovascular and fracture events in patients with SHPT which are the leading causes of death in patients with CKD, and provide a reference for selecting patients for whom surgery is more suitable.</p><p><strong>Methods: </strong>Patients who underwent parathyroidectomy (PTX) for SHPT at The First Affiliated Hospital, Zhejiang University School of Medicine from September 2021 to April 2024 were selected as the study object, with the inclusion and exclusion criteria as followed. They were divided into rural and urban residents for comparison as a cross-sectional study. The study evaluated the comorbidities, socioeconomic status, and postoperative complications diagnosed by radiography of patients undergoing surgery for SHPT.</p><p><strong>Results: </strong>A total of 119 patients were included, among whom, 71 were from rural areas and 48 were from urban areas. Compared with urban residents, rural residents had poorer economic conditions, a longer interval from disease onset to PTX, and a higher incidence of cardiovascular and fracture events and concurrent nephrolithiasis, all of which were statistically significant. Multivariate analysis indicated that place of residence, age, and duration of uremia were independent risk factors of cardiovascular/fracture events.</p><p><strong>Conclusions: </strong>Medical staff in ESRD outpatient clinics should pay attention to patients with SHPT. ESRD patients should have better surveillance especially for rural, elder and poor phosphorus control patients, and promptly assess surgical intervention measures.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480872/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Centralization of adrenal surgeries and improved surgeon volume outcomes. 集中肾上腺手术,提高外科医生的手术量效果。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-19 DOI: 10.21037/gs-24-201
Diluka Pinto, Titus Cvasciuc, Rajeev Parameswaran
{"title":"Centralization of adrenal surgeries and improved surgeon volume outcomes.","authors":"Diluka Pinto, Titus Cvasciuc, Rajeev Parameswaran","doi":"10.21037/gs-24-201","DOIUrl":"https://doi.org/10.21037/gs-24-201","url":null,"abstract":"","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic prediction of breast cancer patients using machine learning models: a retrospective analysis. 利用机器学习模型预测乳腺癌患者的预后:一项回顾性分析。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-106
Xuchun Song, Jiebin Chu, Zijie Guo, Qun Wei, Qingchuan Wang, Wenxian Hu, Linbo Wang, Wenhe Zhao, Heming Zheng, Xudong Lu, Jichun Zhou

Background: Breast cancer is a common and complex disease, with various clinical features affecting prognosis. Accurate prediction of prognosis is essential for guiding personalized treatment strategies. This study aimed to develop machine learning models for predicting prognosis in breast cancer patients using retrospective data.

Methods: A total of 6,477 patients from Affiliated Sir Run Run Shaw Hospital were included, and their electronic medical records (EMRs) were thoroughly examined to identify 15 clinical features significantly associated with breast cancer survival. We employed eight different machine learning algorithms, including Logistic Regression (LR), Support Vector Machine (SVM), Random Forest (RF), and Extreme Gradient Boosting (XGBoost), to develop and evaluate the predictive performance of the models. In addition, to investigate the sensitivity of different training/testing set radio to model performance, we examined five sets of ratios: 50:50, 60:40, 70:30, 80:20, 90:10.

Results: Among these models, XGBoost demonstrated the highest performance with receiver operating characteristic (ROC) area under the curve (AUC) of 0.813, accuracy of 0.739, sensitivity of 0.815, and specificity of 0.735. Further statistical analysis identified several significant predictors of prognosis, including age, tumor size, lymph node status, and hormone receptor status. The XGBoost model was found to exhibit superior predictive power compared to established prognostic models such as the Nottingham Prognostic Index (NPI) and Predict Breast. Based on the successful performance of the XGBoost model, we developed a prognosis prediction tool specifically designed for breast cancer, providing valuable insights to clinicians, and aiding them in making informed treatment decisions tailored to individual patients.

Conclusions: Our study highlights the potential of machine learning models in accurately predicting prognosis for breast cancer patients, ultimately facilitating personalized treatment strategies. Further research and validation are warranted to fully integrate these models into clinical practice.

背景:乳腺癌是一种常见而复杂的疾病,各种临床特征都会影响预后。准确预测预后对于指导个性化治疗策略至关重要。本研究旨在利用回顾性数据开发预测乳腺癌患者预后的机器学习模型:方法:我们纳入了邵逸夫附属医院的6477名患者,并对他们的电子病历(EMR)进行了全面检查,以确定与乳腺癌生存率显著相关的15个临床特征。我们采用了八种不同的机器学习算法,包括逻辑回归(Logistic Regression,LR)、支持向量机(Support Vector Machine,SVM)、随机森林(Random Forest,RF)和极端梯度提升(Extreme Gradient Boosting,XGBoost),来开发和评估模型的预测性能。此外,为了研究不同训练/测试集无线电对模型性能的敏感性,我们研究了五组比例:结果:在这些模型中,XGBoost 的性能最高,接收器操作特征曲线下面积 (ROC) 为 0.813,准确率为 0.739,灵敏度为 0.815,特异性为 0.735。进一步的统计分析发现了几个重要的预后预测因素,包括年龄、肿瘤大小、淋巴结状态和激素受体状态。与诺丁汉预后指数 (NPI) 和乳腺预测 (Predict Breast) 等成熟的预后模型相比,XGBoost 模型的预测能力更胜一筹。基于 XGBoost 模型的成功表现,我们开发了一款专为乳腺癌设计的预后预测工具,为临床医生提供有价值的见解,帮助他们根据患者的具体情况做出明智的治疗决策:我们的研究凸显了机器学习模型在准确预测乳腺癌患者预后方面的潜力,最终促进了个性化治疗策略的制定。要将这些模型完全融入临床实践,还需要进一步的研究和验证。
{"title":"Prognostic prediction of breast cancer patients using machine learning models: a retrospective analysis.","authors":"Xuchun Song, Jiebin Chu, Zijie Guo, Qun Wei, Qingchuan Wang, Wenxian Hu, Linbo Wang, Wenhe Zhao, Heming Zheng, Xudong Lu, Jichun Zhou","doi":"10.21037/gs-24-106","DOIUrl":"https://doi.org/10.21037/gs-24-106","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer is a common and complex disease, with various clinical features affecting prognosis. Accurate prediction of prognosis is essential for guiding personalized treatment strategies. This study aimed to develop machine learning models for predicting prognosis in breast cancer patients using retrospective data.</p><p><strong>Methods: </strong>A total of 6,477 patients from Affiliated Sir Run Run Shaw Hospital were included, and their electronic medical records (EMRs) were thoroughly examined to identify 15 clinical features significantly associated with breast cancer survival. We employed eight different machine learning algorithms, including Logistic Regression (LR), Support Vector Machine (SVM), Random Forest (RF), and Extreme Gradient Boosting (XGBoost), to develop and evaluate the predictive performance of the models. In addition, to investigate the sensitivity of different training/testing set radio to model performance, we examined five sets of ratios: 50:50, 60:40, 70:30, 80:20, 90:10.</p><p><strong>Results: </strong>Among these models, XGBoost demonstrated the highest performance with receiver operating characteristic (ROC) area under the curve (AUC) of 0.813, accuracy of 0.739, sensitivity of 0.815, and specificity of 0.735. Further statistical analysis identified several significant predictors of prognosis, including age, tumor size, lymph node status, and hormone receptor status. The XGBoost model was found to exhibit superior predictive power compared to established prognostic models such as the Nottingham Prognostic Index (NPI) and Predict Breast. Based on the successful performance of the XGBoost model, we developed a prognosis prediction tool specifically designed for breast cancer, providing valuable insights to clinicians, and aiding them in making informed treatment decisions tailored to individual patients.</p><p><strong>Conclusions: </strong>Our study highlights the potential of machine learning models in accurately predicting prognosis for breast cancer patients, ultimately facilitating personalized treatment strategies. Further research and validation are warranted to fully integrate these models into clinical practice.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480873/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiomics and deep learning for large volume lymph node metastasis in papillary thyroid carcinoma. 甲状腺乳头状癌大体积淋巴结转移的放射组学和深度学习。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-18 DOI: 10.21037/gs-24-308
Zhongkai Ni, Tianhan Zhou, Hao Fang, Xiangfeng Lin, Zhiyu Xing, Xiaowen Li, Yangyang Xie, Lihua Hong, Shifei Huang, Jinwang Ding, Hai Huang

Background: Thyroid cancer is prone to early lymph node metastasis (LNM), and patients with large volume LNM (LVLNM) tend to have a poorer prognosis. The aim of this study was to predict LVLNM in before surgery based on radiomics and deep learning (DL).

Methods: A multicenter retrospective study was performed, including 854 papillary thyroid carcinoma (PTC) patients from three centers. Radiomics features were extracted. Logistic regression (LR), support vector machine (SVM), K-nearest neighbors (KNN), multi-layer perceptron (MLP), random forest (RF), ExtraTrees, extreme gradient boosting (XGBoost), and light gradient boosting machine (LightGBM) algorithms were used to construct radiomics models. AlexNet, DenseNet121, inception_v3, ResNet50, and transformer algorithms were used to construct DL models. The receiver operating characteristic (ROC) curve was employed to select the better-performing model. A combined model was then created by merging radiomics features and DL features. The least absolute shrinkage and selection operator (LASSO) method was utilized to identify metabolites and radiomics features with non-zero coefficients. The performance of the models was evaluated using area under the curve (AUC), accuracy (ACC), sensitivity (SEN), specificity (SPE), positive predictive value (PPV), negative predictive value (NPV), and F1-score.

Results: A total of 1,357 radiomics features were extracted. Among the radiomics models, the ExtraTrees model demonstrated the optimal diagnostic capabilities with an AUC of 0.787 [95% confidence interval (CI): 0.715-0.858], and DenseNet121 DL model demonstrated the optimal diagnostic capabilities with an AUC of 0.766 (95% CI: 0.683-0.848). Furthermore, the combined model, named the Thy-DL-Radiomics model, exhibited an AUC of 0.839 (95% CI: 0.758-0.920) in the internal validation set and 0.789 (95% CI: 0.718-0.859) in the external validation set.

Conclusions: A radiomics-DL features integrated model can predict LVLNM in PTC patients and provide guidance for personalized treatment.

背景:甲状腺癌容易发生早期淋巴结转移(LNM),大体积淋巴结转移(LVLNM)患者的预后往往较差。本研究旨在基于放射组学和深度学习(DL)预测手术前的 LVLNM:这项多中心回顾性研究包括来自三个中心的854名甲状腺乳头状癌(PTC)患者。提取了放射组学特征。使用逻辑回归(LR)、支持向量机(SVM)、K-近邻(KNN)、多层感知器(MLP)、随机森林(RF)、ExtraTrees、极梯度提升(XGBoost)和轻梯度提升机(LightGBM)算法构建放射组学模型。AlexNet、DenseNet121、inception_v3、ResNet50 和 transformer 算法用于构建 DL 模型。采用接收者操作特征曲线(ROC)来选择表现较好的模型。然后,通过合并放射组学特征和 DL 特征创建一个组合模型。利用最小绝对收缩和选择算子(LASSO)方法来识别系数不为零的代谢物和放射组学特征。使用曲线下面积(AUC)、准确性(ACC)、灵敏度(SEN)、特异性(SPE)、阳性预测值(PPV)、阴性预测值(NPV)和 F1 分数评估了模型的性能:共提取了 1,357 个放射组学特征。在放射组学模型中,ExtraTrees模型的AUC为0.787[95%置信区间(CI):0.715-0.858],显示出最佳诊断能力;DenseNet121 DL模型的AUC为0.766(95% CI:0.683-0.848),显示出最佳诊断能力。此外,被命名为Thy-DL-Radiomics模型的组合模型在内部验证集中的AUC为0.839(95% CI:0.758-0.920),在外部验证集中的AUC为0.789(95% CI:0.718-0.859):放射组学-DL特征整合模型可预测PTC患者的LVLNM,并为个性化治疗提供指导。
{"title":"Radiomics and deep learning for large volume lymph node metastasis in papillary thyroid carcinoma.","authors":"Zhongkai Ni, Tianhan Zhou, Hao Fang, Xiangfeng Lin, Zhiyu Xing, Xiaowen Li, Yangyang Xie, Lihua Hong, Shifei Huang, Jinwang Ding, Hai Huang","doi":"10.21037/gs-24-308","DOIUrl":"https://doi.org/10.21037/gs-24-308","url":null,"abstract":"<p><strong>Background: </strong>Thyroid cancer is prone to early lymph node metastasis (LNM), and patients with large volume LNM (LVLNM) tend to have a poorer prognosis. The aim of this study was to predict LVLNM in before surgery based on radiomics and deep learning (DL).</p><p><strong>Methods: </strong>A multicenter retrospective study was performed, including 854 papillary thyroid carcinoma (PTC) patients from three centers. Radiomics features were extracted. Logistic regression (LR), support vector machine (SVM), K-nearest neighbors (KNN), multi-layer perceptron (MLP), random forest (RF), ExtraTrees, extreme gradient boosting (XGBoost), and light gradient boosting machine (LightGBM) algorithms were used to construct radiomics models. AlexNet, DenseNet121, inception_v3, ResNet50, and transformer algorithms were used to construct DL models. The receiver operating characteristic (ROC) curve was employed to select the better-performing model. A combined model was then created by merging radiomics features and DL features. The least absolute shrinkage and selection operator (LASSO) method was utilized to identify metabolites and radiomics features with non-zero coefficients. The performance of the models was evaluated using area under the curve (AUC), accuracy (ACC), sensitivity (SEN), specificity (SPE), positive predictive value (PPV), negative predictive value (NPV), and F1-score.</p><p><strong>Results: </strong>A total of 1,357 radiomics features were extracted. Among the radiomics models, the ExtraTrees model demonstrated the optimal diagnostic capabilities with an AUC of 0.787 [95% confidence interval (CI): 0.715-0.858], and DenseNet121 DL model demonstrated the optimal diagnostic capabilities with an AUC of 0.766 (95% CI: 0.683-0.848). Furthermore, the combined model, named the Thy-DL-Radiomics model, exhibited an AUC of 0.839 (95% CI: 0.758-0.920) in the internal validation set and 0.789 (95% CI: 0.718-0.859) in the external validation set.</p><p><strong>Conclusions: </strong>A radiomics-DL features integrated model can predict LVLNM in PTC patients and provide guidance for personalized treatment.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spleen-preserving distal pancreatectomy for intraductal papillary mucinous neoplasm. 导管内乳头状黏液瘤的保脾远端胰腺切除术。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-06 DOI: 10.21037/gs-24-150
Katsunori Sakamoto
{"title":"Spleen-preserving distal pancreatectomy for intraductal papillary mucinous neoplasm.","authors":"Katsunori Sakamoto","doi":"10.21037/gs-24-150","DOIUrl":"https://doi.org/10.21037/gs-24-150","url":null,"abstract":"","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480868/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The establishment and validation of a clinical prediction model for postoperative biliary fistula after pancreaticoduodenectomy. 胰十二指肠切除术后胆道瘘临床预测模型的建立和验证。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-174
Zhengrong Ou, An Yan, Weidong Zhu

Background: At present, pancreaticoduodenectomy (PD) is a classic surgical treatment for benign and malignant tumors around ampulla. The operation is complicated and postoperative complications are frequent. Biliary fistula is the most common anastomotic fistula after pancreatic fistula. Our objective is to analyze the risk factors for biliary fistula after PD and to construct a nomogram to predict biliary fistula after PD.

Methods: The clinical data of a total of 196 patients who underwent PD from March 2014 to March 2024 in Yueyang Hospital Affiliated to Hunan Normal University and The Third Xiangya Hospital of Central South University were retrospectively analyzed. The number of included patients was divided in the ratio of 7:3 using the random split method, with 130 patients in the training set and 66 patients in the validation set. Predictors were screened and a nomogram prediction model was constructed by one-way logistic regression analysis, Lasso regression analysis and multifactorial logistic regression analysis. The discriminative ability, consistency and clinical effectiveness of the models were assessed by area under the curve (AUC) of the working characteristics of the subjects, calibration curve and decision curve analysis (DCA).

Results: The results of multifactorial logistic regression analysis showed that diabetes, low albumin, postoperative gastroparesis, abdominal bleeding, abdominal infection, and postoperative pancreatic fistula were the independent risk factors for biliary fistula after PD (P<0.05). The AUC of the column-line graph prediction model constructed from the above factors was 0.807 [95% confidence interval (CI): 0.652-0.962] in the training set and 0.782 (95% CI: 0.517-1.000) in the validation set, suggesting that the diagnostic efficacy of the model was better, and the calibration curves plotted in the training and validation sets were closer to the standard curves, suggesting that the model consistency was better. The plotted DCA curves also indicated a significant positive net gain.

Conclusions: The nomogram prediction model constructed by diabetes, albumin, postoperative gastroparesis, abdominal bleeding, abdominal infection, and postoperative pancreatic fistula can well identify high-risk patients with postoperative biliary fistula (POBF) in PD, which has a good clinical application value.

背景:目前,胰十二指肠切除术(PD)是治疗安瓿周围良性和恶性肿瘤的经典手术方法。该手术操作复杂,术后并发症频发。胆瘘是继胰瘘之后最常见的吻合口瘘。我们的目的是分析胰瘘术后胆瘘的风险因素,并构建预测胰瘘术后胆瘘的提名图:方法:回顾性分析2014年3月至2024年3月在湖南师范大学附属岳阳医院和中南大学湘雅三医院接受胰十二指肠切除术的196例患者的临床资料。采用随机分割法,将纳入的患者人数按 7:3 的比例进行分割,其中 130 名患者为训练集,66 名患者为验证集。通过单向逻辑回归分析、Lasso 回归分析和多因素逻辑回归分析,筛选出预测因子并构建了提名图预测模型。通过受试者工作特征曲线下面积(AUC)、校正曲线和决策曲线分析(DCA)评估了模型的判别能力、一致性和临床有效性:多因素Logistic回归分析结果显示,糖尿病、低白蛋白、术后胃瘫、腹腔出血、腹腔感染和术后胰瘘是PD术后胆瘘的独立危险因素(PConclusions:由糖尿病、白蛋白、术后胃瘫、腹腔出血、腹腔感染和术后胰瘘构建的提名图预测模型能很好地识别PD术后胆瘘(POBF)的高危患者,具有很好的临床应用价值。
{"title":"The establishment and validation of a clinical prediction model for postoperative biliary fistula after pancreaticoduodenectomy.","authors":"Zhengrong Ou, An Yan, Weidong Zhu","doi":"10.21037/gs-24-174","DOIUrl":"https://doi.org/10.21037/gs-24-174","url":null,"abstract":"<p><strong>Background: </strong>At present, pancreaticoduodenectomy (PD) is a classic surgical treatment for benign and malignant tumors around ampulla. The operation is complicated and postoperative complications are frequent. Biliary fistula is the most common anastomotic fistula after pancreatic fistula. Our objective is to analyze the risk factors for biliary fistula after PD and to construct a nomogram to predict biliary fistula after PD.</p><p><strong>Methods: </strong>The clinical data of a total of 196 patients who underwent PD from March 2014 to March 2024 in Yueyang Hospital Affiliated to Hunan Normal University and The Third Xiangya Hospital of Central South University were retrospectively analyzed. The number of included patients was divided in the ratio of 7:3 using the random split method, with 130 patients in the training set and 66 patients in the validation set. Predictors were screened and a nomogram prediction model was constructed by one-way logistic regression analysis, Lasso regression analysis and multifactorial logistic regression analysis. The discriminative ability, consistency and clinical effectiveness of the models were assessed by area under the curve (AUC) of the working characteristics of the subjects, calibration curve and decision curve analysis (DCA).</p><p><strong>Results: </strong>The results of multifactorial logistic regression analysis showed that diabetes, low albumin, postoperative gastroparesis, abdominal bleeding, abdominal infection, and postoperative pancreatic fistula were the independent risk factors for biliary fistula after PD (P<0.05). The AUC of the column-line graph prediction model constructed from the above factors was 0.807 [95% confidence interval (CI): 0.652-0.962] in the training set and 0.782 (95% CI: 0.517-1.000) in the validation set, suggesting that the diagnostic efficacy of the model was better, and the calibration curves plotted in the training and validation sets were closer to the standard curves, suggesting that the model consistency was better. The plotted DCA curves also indicated a significant positive net gain.</p><p><strong>Conclusions: </strong>The nomogram prediction model constructed by diabetes, albumin, postoperative gastroparesis, abdominal bleeding, abdominal infection, and postoperative pancreatic fistula can well identify high-risk patients with postoperative biliary fistula (POBF) in PD, which has a good clinical application value.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intragallbladder versus intravenous indocyanine green (ICG) injection for enhanced bile duct visualization by fluorescent cholangiography during laparoscopic cholecystectomy: a retrospective cohort study. 在腹腔镜胆囊切除术中通过荧光胆管造影增强胆管显像时,膀胱内注射吲哚青绿(ICG)还是静脉注射吲哚青绿(ICG):一项回顾性队列研究。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-198
Yu Cai, Qiangxing Chen, Ke Cheng, Zixin Chen, Shangdi Wu, Zhong Wu, Xin Wang, Yongbin Li, Andrea Balla, Anurag Singh, He Cai, Pan Gao, Yunqiang Cai, Bing Peng

Background: Iatrogenic bile duct injuries (BDIs) prevention during laparoscopic cholecystectomy (LC) relies on meticulous anatomical dissections through direct visualization. Near-infrared fluorescence (NIRF) with indocyanine green (ICG) improves the visualization of extrahepatic biliary structures. Although ICG can be administered either intravenously or intragallbladder, there remains uncertainty regarding the optimal method for different patient populations. This study sought to assess the suitability of each method for specific patient groups.

Methods: Between October 2021 and May 2022, 59 consecutive patients underwent fluorescence-guided LC at West China Hospital of Sichuan University. Among them, 32 patients received an intravenous injection of ICG (10 mg) 10 to 12 hours prior to surgery (Group A: the intravenous group), while 27 patients received an intragallbladder injection of ICG (10 mg) (Group B: the intragallbladder group). Baseline clinical factors, inclusion criteria, and measurements of parameters and complications were assessed. Data were retrospectively collected and analyzed to evaluate the comparability of the two groups and the clinical outcomes.

Results: Groups A and B included 32 patients (18 males, 14 females), and 27 patients (13 men, 14 women), respectively. In our statistical analysis, significant differences were observed in preoperative diagnoses between the two groups (P=0.041), but the majority of other baseline clinical factors were comparable. Notably, no statistically significant differences were found in complication rates. However, Group A had a shorter operative time (60.38±9.35 vs. 66.78±9.88 min, P=0.01) and superior bile duct fluorescence (P=0.04) than Group B. Interestingly, fluorescence was not observed in impacted gallbladder stones in Group B. Additionally, patients with cirrhosis (P=0.008) and fatty liver (P=0.005) in Group B had higher common bile duct-to-liver ratios (BLRs) than those in Group A.

Conclusions: ICG fluorescence cholangiography allows to visualize extrahepatic biliary anatomical structures with both administration methods. However, the efficacy of bile duct fluorescence varies with different administration routes in diverse patient populations. Hence, appropriate administration route selection for ICG should be tailored to individual patients.

背景:腹腔镜胆囊切除术(LC)中预防先天性胆管损伤(BDIs)有赖于通过直接可视化进行细致的解剖解剖。使用吲哚青绿(ICG)的近红外荧光(NIRF)可改善肝外胆管结构的可视化。虽然 ICG 既可以静脉注射,也可以膀胱内注射,但对于不同的患者群体,最佳的方法仍不确定。本研究旨在评估每种方法对特定患者群体的适用性:方法:2021 年 10 月至 2022 年 5 月期间,四川大学华西医院连续为 59 名患者实施了荧光引导下膀胱造影术。其中,32例患者在术前10至12小时静脉注射ICG(10毫克)(A组:静脉注射组),27例患者在术前10至12小时膀胱内注射ICG(10毫克)(B组:膀胱内注射组)。对基线临床因素、纳入标准、参数测量和并发症进行了评估。对数据进行回顾性收集和分析,以评估两组的可比性和临床结果:结果:A组和B组分别有32名患者(18名男性,14名女性)和27名患者(13名男性,14名女性)。在我们的统计分析中,两组患者的术前诊断存在显著差异(P=0.041),但其他大多数基线临床因素具有可比性。值得注意的是,两组在并发症发生率上没有明显的统计学差异。然而,与 B 组相比,A 组的手术时间更短(60.38±9.35 分钟 vs. 66.78±9.88 分钟,P=0.01),胆管荧光更强(P=0.04)。此外,与 A 组相比,B 组肝硬化(P=0.008)和脂肪肝(P=0.005)患者的总胆管肝比(BLRs)更高:结论:ICG 荧光胆管造影可通过两种给药方法观察肝外胆道解剖结构。然而,在不同的患者群体中,不同的给药途径所产生的胆管荧光效果也不尽相同。因此,应根据患者的具体情况选择合适的 ICG 给药途径。
{"title":"Intragallbladder versus intravenous indocyanine green (ICG) injection for enhanced bile duct visualization by fluorescent cholangiography during laparoscopic cholecystectomy: a retrospective cohort study.","authors":"Yu Cai, Qiangxing Chen, Ke Cheng, Zixin Chen, Shangdi Wu, Zhong Wu, Xin Wang, Yongbin Li, Andrea Balla, Anurag Singh, He Cai, Pan Gao, Yunqiang Cai, Bing Peng","doi":"10.21037/gs-24-198","DOIUrl":"https://doi.org/10.21037/gs-24-198","url":null,"abstract":"<p><strong>Background: </strong>Iatrogenic bile duct injuries (BDIs) prevention during laparoscopic cholecystectomy (LC) relies on meticulous anatomical dissections through direct visualization. Near-infrared fluorescence (NIRF) with indocyanine green (ICG) improves the visualization of extrahepatic biliary structures. Although ICG can be administered either intravenously or intragallbladder, there remains uncertainty regarding the optimal method for different patient populations. This study sought to assess the suitability of each method for specific patient groups.</p><p><strong>Methods: </strong>Between October 2021 and May 2022, 59 consecutive patients underwent fluorescence-guided LC at West China Hospital of Sichuan University. Among them, 32 patients received an intravenous injection of ICG (10 mg) 10 to 12 hours prior to surgery (Group A: the intravenous group), while 27 patients received an intragallbladder injection of ICG (10 mg) (Group B: the intragallbladder group). Baseline clinical factors, inclusion criteria, and measurements of parameters and complications were assessed. Data were retrospectively collected and analyzed to evaluate the comparability of the two groups and the clinical outcomes.</p><p><strong>Results: </strong>Groups A and B included 32 patients (18 males, 14 females), and 27 patients (13 men, 14 women), respectively. In our statistical analysis, significant differences were observed in preoperative diagnoses between the two groups (P=0.041), but the majority of other baseline clinical factors were comparable. Notably, no statistically significant differences were found in complication rates. However, Group A had a shorter operative time (60.38±9.35 <i>vs.</i> 66.78±9.88 min, P=0.01) and superior bile duct fluorescence (P=0.04) than Group B. Interestingly, fluorescence was not observed in impacted gallbladder stones in Group B. Additionally, patients with cirrhosis (P=0.008) and fatty liver (P=0.005) in Group B had higher common bile duct-to-liver ratios (BLRs) than those in Group A.</p><p><strong>Conclusions: </strong>ICG fluorescence cholangiography allows to visualize extrahepatic biliary anatomical structures with both administration methods. However, the efficacy of bile duct fluorescence varies with different administration routes in diverse patient populations. Hence, appropriate administration route selection for ICG should be tailored to individual patients.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480876/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early detection of concomitant pancreatic cancer during intraductal papillary mucinous neoplasms surveillance. 在导管内乳头状粘液瘤监测期间及早发现并发胰腺癌。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-12 DOI: 10.21037/gs-24-158
Joanna Jiang, Somashekar G Krishna
{"title":"Early detection of concomitant pancreatic cancer during intraductal papillary mucinous neoplasms surveillance.","authors":"Joanna Jiang, Somashekar G Krishna","doi":"10.21037/gs-24-158","DOIUrl":"https://doi.org/10.21037/gs-24-158","url":null,"abstract":"","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480875/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of location and size of minimal extrathyroidal extension on lymph node metastasis in papillary thyroid cancer: a retrospective analysis. 甲状腺乳头状癌最小甲状腺外扩展的位置和大小对淋巴结转移的影响:一项回顾性分析。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-273
Hongliang Zhan, Yiyan Hong, Longying Zhang, Kunzhai Huang, Miaomiao Zheng, Fuxing Zhang

Background: The 8th edition of the American Joint Committee on Cancer (AJCC)'s T-stage for differentiated thyroid cancer (DTC) removes minimal extrathyroidal extension (mETE), while ignoring the risk of mETE would lead to overtreatment or inadequate treatment. The aim of this study was to investigate the impact of location and size of mETE on lymph node metastasis in papillary thyroid cancer (PTC).

Methods: A retrospective analysis of 267 patients who underwent unilateral radical surgery for PTC was conducted. According to the postoperative pathology, they were divided into mETE group (121 patients) and non-mETE group (146 patients). The number of lymph nodes dissected and the number of lymph nodes metastasized were compared between the two groups. The linear regression analysis and the receiver operating characteristic (ROC) curves were performed to evaluate the impact of the locations and sizes on lymph node metastasis.

Results: There was no significant difference in the number of lymph node dissected between the mETE group and the non-mETE group. The tumor located at the upper part and the size <1.0 cm in mETE group showed a higher number of lymph node metastasis (0.78±0.88 vs. 0.25±0.45, P=0.03). Meanwhile, in the mETE group, the number of patients with lymph node metastasis was higher than that in the non-mETE group. Further subgroup analysis revealed that for PTC patients with tumors at the upper part and size <1.0 cm, the number of those with lymph node metastasis in the mETE group was also greater than that in the non-mETE group. Furthermore, the Spearman correlation analysis showed a positive correlation between tumors located at the upper part with a size <1.0 cm and lymph node metastasis rate (R=0.647, P=0.004). Additionally, if the upper part tumor was within 1 cm, the tumor's size was able to identify the lymph node metastasis, with the optimal cut-off point of 0.45 cm (Youden index =0.650).

Conclusions: When tumors combine with mETE, the probability of lymph node metastasis increases in tumors located at the upper part with a size <1.0 cm. Especially, when the upper part tumor is within 1 cm, the tumors of size ≥0.45 cm are more likely to have lymph node metastasis.

背景:美国癌症联合委员会(AJCC)第8版的分化型甲状腺癌(DTC)T分期删除了最小甲状腺外扩展(mETE),而忽视mETE的风险将导致过度治疗或治疗不当。本研究旨在探讨mETE的位置和大小对甲状腺乳头状癌(PTC)淋巴结转移的影响:方法:对267例接受单侧PTC根治术的患者进行回顾性分析。根据术后病理结果,将患者分为 mETE 组(121 例)和非 mETE 组(146 例)。比较了两组患者的淋巴结清扫数量和淋巴结转移数量。通过线性回归分析和接收者操作特征曲线(ROC)来评估位置和大小对淋巴结转移的影响:结果:mETE 组与非 mETE 组切除的淋巴结数量无明显差异。mETE组淋巴结清扫数量与非mETE组无明显差异(肿瘤位于上部、大小为0.25±0.45,P=0.03)。同时,在mETE组中,淋巴结转移的患者数量高于非mETE组。进一步的亚组分析表明,对于肿瘤位于上部且大小结论的 PTC 患者,mETE 组的淋巴结转移数量高于非 mETE 组:当肿瘤合并 mETE 时,位于肿瘤上部、大小为 0.5 mm×0.5 mm 的肿瘤发生淋巴结转移的概率会增加。
{"title":"Impact of location and size of minimal extrathyroidal extension on lymph node metastasis in papillary thyroid cancer: a retrospective analysis.","authors":"Hongliang Zhan, Yiyan Hong, Longying Zhang, Kunzhai Huang, Miaomiao Zheng, Fuxing Zhang","doi":"10.21037/gs-24-273","DOIUrl":"https://doi.org/10.21037/gs-24-273","url":null,"abstract":"<p><strong>Background: </strong>The 8th edition of the American Joint Committee on Cancer (AJCC)'s T-stage for differentiated thyroid cancer (DTC) removes minimal extrathyroidal extension (mETE), while ignoring the risk of mETE would lead to overtreatment or inadequate treatment. The aim of this study was to investigate the impact of location and size of mETE on lymph node metastasis in papillary thyroid cancer (PTC).</p><p><strong>Methods: </strong>A retrospective analysis of 267 patients who underwent unilateral radical surgery for PTC was conducted. According to the postoperative pathology, they were divided into mETE group (121 patients) and non-mETE group (146 patients). The number of lymph nodes dissected and the number of lymph nodes metastasized were compared between the two groups. The linear regression analysis and the receiver operating characteristic (ROC) curves were performed to evaluate the impact of the locations and sizes on lymph node metastasis.</p><p><strong>Results: </strong>There was no significant difference in the number of lymph node dissected between the mETE group and the non-mETE group. The tumor located at the upper part and the size <1.0 cm in mETE group showed a higher number of lymph node metastasis (0.78±0.88 <i>vs.</i> 0.25±0.45, P=0.03). Meanwhile, in the mETE group, the number of patients with lymph node metastasis was higher than that in the non-mETE group. Further subgroup analysis revealed that for PTC patients with tumors at the upper part and size <1.0 cm, the number of those with lymph node metastasis in the mETE group was also greater than that in the non-mETE group. Furthermore, the Spearman correlation analysis showed a positive correlation between tumors located at the upper part with a size <1.0 cm and lymph node metastasis rate (R=0.647, P=0.004). Additionally, if the upper part tumor was within 1 cm, the tumor's size was able to identify the lymph node metastasis, with the optimal cut-off point of 0.45 cm (Youden index =0.650).</p><p><strong>Conclusions: </strong>When tumors combine with mETE, the probability of lymph node metastasis increases in tumors located at the upper part with a size <1.0 cm. Especially, when the upper part tumor is within 1 cm, the tumors of size ≥0.45 cm are more likely to have lymph node metastasis.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480871/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy. 基于计算机断层扫描的放射组学和身体成分分析预测胰十二指肠切除术后胰瘘的临床相关性。
IF 1.5 3区 医学 Q3 SURGERY Pub Date : 2024-09-30 Epub Date: 2024-09-27 DOI: 10.21037/gs-24-167
Hongyu Wu, Dajun Yu, Jinzheng Li, Xiaojing He, Chunli Li, Shengwei Li, Xiong Ding

Background: Preoperative risk assessment of clinically relevant postoperative pancreatic fistula (CR-POPF) is still lacking. This study aimed to develop and validate a combined model based on radiomics, pancreatic duct diameter, and body composition analysis for the prediction of CR-POPF in patients undergoing pancreaticoduodenectomy (PD).

Methods: Multivariable logistic regression was used to construct a combined model in conjunction with radiomics score (Rad-score), pancreatic duct diameter, and visceral fat area/total abdominal muscle area index (VFA/TAMAI). The models were internally validated using 1,000 bootstrap resamples. The predictive performance of these models was assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).

Results: The preoperative combined model was validated by 1,000 bootstrap resampling with the area under the ROC curve (AUC) of 0.839 (95% confidence interval: 0.757-0.907). The calibration curves and DCA showed that the combined model outperformed the clinical model and radiomics model. The combined model was presented as a web-based calculator (https://whyyjyljz.shinyapps.io/DynNomapp/).

Conclusions: We explored a method of combining radiomics features, pancreatic duct diameter, and body composition analysis predictors in preoperative assessment for risk of CR-POPF and developed a combined model that showed relatively good performance, but future studies with a larger sample size are needed to verify the stability and generalizability of this model.

背景:目前仍缺乏对临床相关术后胰瘘(CR-POPF)的术前风险评估。本研究旨在开发并验证一个基于放射组学、胰管直径和身体成分分析的联合模型,用于预测接受胰十二指肠切除术(PD)患者的 CR-POPF:方法:采用多变量逻辑回归法结合放射组学评分(Rad-score)、胰管直径和内脏脂肪面积/腹肌总面积指数(VFA/TAMAI)构建综合模型。使用 1,000 个引导重采样对模型进行了内部验证。使用接收器操作特征曲线(ROC)、校准曲线和决策曲线分析(DCA)对这些模型的预测性能进行了评估:结果:术前综合模型通过 1,000 次引导重采样得到验证,其 ROC 曲线下面积(AUC)为 0.839(95% 置信区间:0.757-0.907)。校准曲线和 DCA 显示,组合模型的性能优于临床模型和放射组学模型。综合模型以网络计算器的形式呈现(https://whyyjyljz.shinyapps.io/DynNomapp/)。结论:我们探索了一种方法,将放射组学特征、胰管直径和身体成分分析预测指标结合起来,用于术前评估 CR-POPF 的风险,并建立了一个综合模型,该模型表现相对较好,但未来需要更大样本量的研究来验证该模型的稳定性和普适性。
{"title":"Computed tomography-based radiomics and body composition analysis for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy.","authors":"Hongyu Wu, Dajun Yu, Jinzheng Li, Xiaojing He, Chunli Li, Shengwei Li, Xiong Ding","doi":"10.21037/gs-24-167","DOIUrl":"https://doi.org/10.21037/gs-24-167","url":null,"abstract":"<p><strong>Background: </strong>Preoperative risk assessment of clinically relevant postoperative pancreatic fistula (CR-POPF) is still lacking. This study aimed to develop and validate a combined model based on radiomics, pancreatic duct diameter, and body composition analysis for the prediction of CR-POPF in patients undergoing pancreaticoduodenectomy (PD).</p><p><strong>Methods: </strong>Multivariable logistic regression was used to construct a combined model in conjunction with radiomics score (Rad-score), pancreatic duct diameter, and visceral fat area/total abdominal muscle area index (VFA/TAMAI). The models were internally validated using 1,000 bootstrap resamples. The predictive performance of these models was assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis (DCA).</p><p><strong>Results: </strong>The preoperative combined model was validated by 1,000 bootstrap resampling with the area under the ROC curve (AUC) of 0.839 (95% confidence interval: 0.757-0.907). The calibration curves and DCA showed that the combined model outperformed the clinical model and radiomics model. The combined model was presented as a web-based calculator (https://whyyjyljz.shinyapps.io/DynNomapp/).</p><p><strong>Conclusions: </strong>We explored a method of combining radiomics features, pancreatic duct diameter, and body composition analysis predictors in preoperative assessment for risk of CR-POPF and developed a combined model that showed relatively good performance, but future studies with a larger sample size are needed to verify the stability and generalizability of this model.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2024-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11480874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142463243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gland surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1